Pharsight

Omnivium Pharms patents expiration

1. Numbrino patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10231961 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10973811 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10894012 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10857095 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10420760 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10413505 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10149843 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10016407 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US9867815 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10933060 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US11040032 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Jan 10, 2023

Drugs and Companies using COCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 10 January, 2020

Treatment: A method for treating a subject with uveal melanoma with unresectable hepatic metastases; Method for the induction of local anesthesia of the mucous membranes; Method for the induction of local anesth...

Dosage: SOLUTION;NASAL

More Information on Dosage

NUMBRINO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic